GCGR具有升糖作用,为何还能成为减重靶点?
肥胖及相关代谢性疾病不仅表现为能量摄入和脂肪储存增加,还伴随肝脏糖脂代谢、底物利用和氨基酸稳态异常。GCGR是调控空腹状态下肝脏底物动员的重要Class B1 ...
用于检测、定量和定位抗原与抗体的技术——ELISA、免疫印迹、免疫组化与流式细胞术。以下是我们知识库中标注该主题的实验方案、常见问题与技术文章。
肥胖及相关代谢性疾病不仅表现为能量摄入和脂肪储存增加,还伴随肝脏糖脂代谢、底物利用和氨基酸稳态异常。GCGR是调控空腹状态下肝脏底物动员的重要Class B1 ...
Obesity and related metabolic diseases are characterized not only by increased energy intake and fat storage but also by abnormalities in hepatic glucose and lipid metabolism, substrate utilization, and amino acid homeostasis. GCGR is an important Class B1 GPCR that regulates hepatic substrate ...
GLP-1R、GIPR与GCGR共同调节胰岛激素分泌、肝糖输出、摄食行为和能量代谢。多受体激动剂通过平衡降糖、食欲抑制与能量消耗作用,提高肥胖症和2型糖尿病的综合代谢干预效果。
GLP-1R, GIPR, and GCGR jointly regulate pancreatic hormone secretion, hepatic glucose output, feeding behavior, and energy metabolism. Multi-receptor agonists improve the overall metabolic treatment of obesity and type 2 diabetes by balancing glucose-lowering effects, appetite suppression, and ...
常与免疫学实验一起研究的技术。